{"id":"W3100080748","doi":"10.1158/1078-0432.ccr-20-3305","title":"Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; Bristol-Myers Squibb; AstraZeneca; York University; Syndax Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Genentech; Parker Institute for Cancer Immunotherapy; Damon Runyon Cancer Research Foundation; Roswell Park Cancer Institute","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038317,0.000249769,0.0007571877,0.0001609201,0.00009764968,0.00005615157,0.0002646439,0.0001045941,0.0007424771],"category_scores_gemma":[0.0001923272,0.0001521569,0.0001349486,0.00133816,0.0006004386,0.0001208085,0.00005907902,0.000956214,0.00003274246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002928638,"about_ca_system_score_gemma":0.001220618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001054705,"about_ca_topic_score_gemma":0.0002403482,"domain_scores_codex":[0.9962026,0.0005390008,0.0006632644,0.0007144156,0.001140222,0.0007404676],"domain_scores_gemma":[0.9980989,0.0004261113,0.0001270251,0.0004430478,0.0004891442,0.0004157921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1390482,0.0007449473,0.8017967,0.0001524028,0.0004900069,0.0001484874,0.0005453348,0.000008987016,0.0001222495,0.00000433788,0.002284913,0.05465348],"study_design_scores_gemma":[0.06528573,0.0127011,0.9057915,0.0005598094,0.0000706888,0.00000411622,0.0001725344,0.0001041215,0.0005225693,0.000005111255,0.01451039,0.0002723007],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908598,0.002082131,0.00001264737,0.003932058,0.00004616072,0.002394645,0.000028645,0.00005297596,0.0005909057],"genre_scores_gemma":[0.9940203,0.003069054,0.0001112134,0.002038291,0.000139815,0.000218107,0.00005406994,0.00006563696,0.0002835566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1039948,"threshold_uncertainty_score":0.8129604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1847118665902934,"score_gpt":0.4600124273515743,"score_spread":0.2753005607612809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}